Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3W09

Influenza virus neuraminidase subtype N9 (TERN) complexed with 2,3-dif guanidino-neu5ac2en inhibitor

3W09 の概要
エントリーDOI10.2210/pdb3w09/pdb
関連するPDBエントリー1NNC 7NN9
分子名称Neuraminidase, alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (8 entities in total)
機能のキーワードneuraminidase, sialidase, hydrolase(o-glucosyl), hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
由来する生物種Influenza A virus
細胞内の位置Virion membrane (By similarity): P03472
タンパク質・核酸の鎖数1
化学式量合計46963.80
構造登録者
Streltsov, V.A. (登録日: 2012-10-25, 公開日: 2013-05-01, 最終更新日: 2024-10-16)
主引用文献Kim, J.-H.,Resende, R.,Wennekes, T.,Chen, H.M.,Bance, N.,Buchini, S.,Watts, A.G.,Pilling, P.,Streltsov, V.A.,Petric, M.,Liggins, R.,Barrett, S.,McKimm-Breschkin, J.L.,Niikura, M.,Withers, S.G.
Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity
Science, 340:71-75, 2013
Cited by
PubMed Abstract: Influenza antiviral agents play important roles in modulating disease severity and in controlling pandemics while vaccines are prepared, but the development of resistance to agents like the commonly used neuraminidase inhibitor oseltamivir may limit their future utility. We report here on a new class of specific, mechanism-based anti-influenza drugs that function through the formation of a stabilized covalent intermediate in the influenza neuraminidase enzyme, and we confirm this mode of action with structural and mechanistic studies. These compounds function in cell-based assays and in animal models, with efficacies comparable to that of the neuraminidase inhibitor zanamivir and with broad-spectrum activity against drug-resistant strains in vitro. The similarity of their structure to that of the natural substrate and their mechanism-based design make these attractive antiviral candidates.
PubMed: 23429702
DOI: 10.1126/science.1232552
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2 Å)
構造検証レポート
Validation report summary of 3w09
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon